BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 379206)

  • 21. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunochemical characterization of cell wall protein antigen purified from the cell wall autolysate of Clostridium botulinum type A.
    Takumi K; Kawata T
    Jpn J Microbiol; 1975 Feb; 19(1):1-6. PubMed ID: 51110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment of proteolytic Clostridium botulinum in canned foie gras.
    Membré JM; Diao M; Thorin C; Cordier G; Zuber F; André S
    Int J Food Microbiol; 2015 Oct; 210():62-72. PubMed ID: 26093992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and grouping of Clostridium botulinum strains by numerical analysis of their electrophoretic protein patterns.
    Bom IJ; Smelt JP; Kersters K; Verrips CT
    J Appl Bacteriol; 1986 Jun; 60(6):483-90. PubMed ID: 3528110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium sporogenes isolates and their relationship to C. botulinum based on deoxyribonucleic acid reassociation.
    Nakamura S; Okado I; Nakashio S; Nishida S
    J Gen Microbiol; 1977 Jun; 100(2):395-401. PubMed ID: 330814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of Genome-Based Discrimination between Clostridium botulinum Group I and Clostridium sporogenes Strains for Bacterial Taxonomy.
    Weigand MR; Pena-Gonzalez A; Shirey TB; Broeker RG; Ishaq MK; Konstantinidis KT; Raphael BH
    Appl Environ Microbiol; 2015 Aug; 81(16):5420-9. PubMed ID: 26048939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Demonstration of 2 main serological groups in Clostridium tyrobutyricum].
    Bergère JL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(1):75-91. PubMed ID: 2417541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strains of Clostridium botulinum subtype Af.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):215-20. PubMed ID: 77604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the interrelationships between the soluble antigens of Cl. septicum and Cl. histolyticum].
    Zemlianitskaia EP; Ermakova MP; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):143-4. PubMed ID: 1199582
    [No Abstract]   [Full Text] [Related]  

  • 34. Demonstration of common antigens on cell surface of Clostridium chauvoei and C. septicum by indirect-immunofluorescence assay.
    Hamaoka T; Terakado N
    J Vet Med Sci; 1994 Apr; 56(2):371-3. PubMed ID: 8075228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative immunochemical study of the antigenic makeup of native tetanus toxin from sporulating and nonsporulating C1. tetani strains].
    Volgin IuB; Réthy L; Ráskai M
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):47-51. PubMed ID: 821277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a commercial latex test for Clostridium difficile for reactivity with C. difficile and cross-reactions with other bacteria.
    Miles BL; Siders JA; Allen SD
    J Clin Microbiol; 1988 Nov; 26(11):2452-5. PubMed ID: 3235677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal spore germination in Clostridium botulinum ATCC 3502 requires the presence of functional copies of SleB and YpeB, but not CwlJ.
    Meaney CA; Cartman ST; McClure PJ; Minton NP
    Anaerobe; 2015 Aug; 34():86-93. PubMed ID: 25937262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the use of the bioMerieux Rapid ID32 A for the identification of Clostridium botulinum.
    Brett MM
    Lett Appl Microbiol; 1998 Jan; 26(1):81-4. PubMed ID: 9489040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity in molecular mass of the common EDTA-soluble antigens of Clostridium chauvoei and Clostridium septicum.
    Hamaoka T; Terakado N; Nakamura S
    Microbiol Immunol; 1994; 38(2):149-52. PubMed ID: 7518890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of a common cell wall antigen from the proteolytic strains of Clostridium botulinum.
    Takumi K; Kawata T
    Jpn J Microbiol; 1974 Jan; 18(1):85-90. PubMed ID: 4212113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.